Fabry disease
Dominique P. Germain(Assistance Publique – Hôpitaux de Paris)
Cited by 1,173
Related Papers
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
|Journal of Medical Genetics|2015|363
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
|Journal of Medical Genetics|2016|147